Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis.
Beatrice MainoliGonçalo S DuarteJoão CostaJoaquim FerreiraDaniel CaldeiraPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)
Twice-daily ASA was associated with a greater antiplatelet effect compared with standard once-daily ASA.